Professional Documents
Culture Documents
"EPIDEMIOLOGY OF TYPHOID"………………
Prepared by:
Vadhadiya Tulsiben Kishorkumar
Guided by:
DR.L.P.PANDEY
-: CERTIFICATE:-
……………………………………………………………... ……….
Date:-
Place:-
➡ Incubation period is typically about 10-14 days but can be longer, and
the onset may be insidious. - Symptoms are often non- specific and
clinically non- distinguishable from other febrile illnesses.
➡. However, clinical severity varies and severe cases may lead to serious
complications or even death.
CLINICAL FEATURES
➡ 1 (1ST WEEK)
• Slowly rising (stepladder fashion) of temperature for 45 days
• Malaise
• Headache Constipation
☛ Rose spots
➡ Stage 3 (3D WEEK) • Febrile become taxic & anorexic
• Significant weight loss Typhoid state (Apathy, confusion & psychosis)
High risk (5-10%) of hemorrhage and perfaration may cause death.
Bacteria invade the gallbladder, biliary system and lymphatic tissue of the
bowel multiply in high number.and pass into stool.
COMPLICATIONS
➡ The most severe complication of typhoid fever is the development of
perforation in the intestine which can lead to the contents of the intestine
leak into the abdominal cavity It may also result in internal bleeding Other
less common complications include:
. ulcers in intestinal
DIAGNOSIS
• Blood culture
• Incubated at 3 º covernight
☛WIDAL TEST
Other non- specific lab studies
TREATMENT
• Activity - rest is helpful
➡ Always drink boiled water Avoid untreated water use bottled water
➡ Always wash fruits and vegetables before use
➡ Get vaccinated
CONCLUSION
Morbidity and mortality from typhoid fever remain an
important problem for public health authorities in developing
countries.
Control of the disease was conducted with effective antibiotics,
unfortunately the emergence and the world-wide spread of S. typhi
strains that are resistant to most previously useful antibiotics raises
again the question of an effective tool for controlling this disease.
As a consequence, there is renewed interest to better
understand the epidemiology of typhoid fever and some
aspects of its pathogenesis.
More importantly, perhaps, there is much pre-occupation in
exploring expanded roles for typhoid vaccines.
One important challenge for public health authorities is to devise
ways to utilise the two currently available improved typhoid
vaccines, oral Ty2la and parenteral Vi polysaccharide, in large-
scale school-based immunisation programs and monitor the public
health impact.
Since humans constitute the reservoir of typhoid infection through
shoft-term and long-term carriers, vaccines that actually prevent
infection with wild type ^S. typhi as well as conferring protection
against clinical illness can, if used in con- junction with other
control measures, help eradicates. typhi disease even in less-
developed regions of the world.